
William A. Craigo
Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 936 |
| Issued Applications | 383 |
| Pending Applications | 126 |
| Abandoned Applications | 445 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18075895
[patent_doc_number] => 20220401507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => Marijuana Chew
[patent_app_type] => utility
[patent_app_number] => 17/230734
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/230734 | Marijuana Chew | Jun 16, 2021 | Abandoned |
Array
(
[id] => 17109932
[patent_doc_number] => 20210290529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => Edible High Nutrient Density Composite and the Use for Reduction and Management of Human Hypertension
[patent_app_type] => utility
[patent_app_number] => 17/340025
[patent_app_country] => US
[patent_app_date] => 2021-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340025 | Edible High Nutrient Density Composite and the Use for Reduction and Management of Human Hypertension | Jun 5, 2021 | Abandoned |
Array
(
[id] => 18449720
[patent_doc_number] => 20230190996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Bio-Material Composition and Methods of Use in Craniomaxillofacial Surgery
[patent_app_type] => utility
[patent_app_number] => 18/000192
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000192
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000192 | Bio-Material Composition and Methods of Use in Craniomaxillofacial Surgery | May 26, 2021 | Pending |
Array
(
[id] => 17633816
[patent_doc_number] => 11344520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
[patent_app_type] => utility
[patent_app_number] => 17/322151
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5927
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/322151 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug | May 16, 2021 | Issued |
Array
(
[id] => 17648434
[patent_doc_number] => 11351133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
[patent_app_type] => utility
[patent_app_number] => 17/322094
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5921
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/322094 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug | May 16, 2021 | Issued |
Array
(
[id] => 18003561
[patent_doc_number] => 20220362327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => COMPOSITIONS AND METHODS FOR WOUND HEALING
[patent_app_type] => utility
[patent_app_number] => 17/319691
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319691 | COMPOSITIONS AND METHODS FOR WOUND HEALING | May 12, 2021 | Abandoned |
Array
(
[id] => 17988759
[patent_doc_number] => 20220354796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => REALIZING THE NANO-AMORPHOUS STATE OF MATERIALS INSIDE NANO-POROUS TEMPLATES
[patent_app_type] => utility
[patent_app_number] => 17/313528
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313528
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313528 | Realizing the nano-amorphous state of materials inside nano-porous templates | May 5, 2021 | Issued |
Array
(
[id] => 17290940
[patent_doc_number] => 20210386779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => COMPOSITIONS AND METHODS FOR DIETARY ENHANCEMENT OF IMMUNE SYSTEM FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/245415
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245415 | COMPOSITIONS AND METHODS FOR DIETARY ENHANCEMENT OF IMMUNE SYSTEM FUNCTION | Apr 29, 2021 | Abandoned |
Array
(
[id] => 20534388
[patent_doc_number] => 12551439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Flowpack for oral delivery of active ingredients
[patent_app_type] => utility
[patent_app_number] => 17/245279
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16650
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245279 | Flowpack for oral delivery of active ingredients | Apr 29, 2021 | Issued |
Array
(
[id] => 18467088
[patent_doc_number] => 20230201369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => NALOXONE NANOPARTICLE COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/996562
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996562 | NALOXONE NANOPARTICLE COMPOSITIONS AND METHODS THEREOF | Apr 28, 2021 | Pending |
Array
(
[id] => 17168695
[patent_doc_number] => 20210322365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => POLYCANNABINOIDS, COMPOUNDS, COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/232432
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232432
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/232432 | Polycannabinoids, compounds, compositions and methods of use | Apr 15, 2021 | Issued |
Array
(
[id] => 16990036
[patent_doc_number] => 20210228456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Method for Improving an Athlete's Gripping Performance and Deterring Perspiration
[patent_app_type] => utility
[patent_app_number] => 17/228304
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228304
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228304 | Method for Improving an Athlete's Gripping Performance and Deterring Perspiration | Apr 11, 2021 | Abandoned |
Array
(
[id] => 17183697
[patent_doc_number] => 20210330582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
[patent_app_type] => utility
[patent_app_number] => 17/227236
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227236 | Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same | Apr 8, 2021 | Abandoned |
Array
(
[id] => 20200330
[patent_doc_number] => 12403094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Rheological solid oral composition
[patent_app_type] => utility
[patent_app_number] => 17/225149
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7273
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/225149 | Rheological solid oral composition | Apr 7, 2021 | Issued |
Array
(
[id] => 17154790
[patent_doc_number] => 20210315841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => CYCLOBENZAPRINE TREATMENT FOR SEXUAL DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/226058
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17226058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/226058 | CYCLOBENZAPRINE TREATMENT FOR SEXUAL DYSFUNCTION | Apr 7, 2021 | Pending |
Array
(
[id] => 18374373
[patent_doc_number] => 20230149452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => STRUCTURALLY DEFINED, BETTER TOLERATED, ORALLY ADMINSTERED, PROCESSED ARSENOLITE, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/917294
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917294 | STRUCTURALLY DEFINED, BETTER TOLERATED, ORALLY ADMINSTERED, PROCESSED ARSENOLITE, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND USES THEREOF | Apr 5, 2021 | Pending |
Array
(
[id] => 18321198
[patent_doc_number] => 20230119326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => BIOABSORBABLE MEDICAL MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/907336
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907336 | BIOABSORBABLE MEDICAL MATERIAL | Mar 30, 2021 | Pending |
Array
(
[id] => 17472545
[patent_doc_number] => 20220080049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => INTRACAMERAL IMPLANT FOR TREATMENT OF AN OCULAR CONDITION
[patent_app_type] => utility
[patent_app_number] => 17/212645
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212645
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212645 | INTRACAMERAL IMPLANT FOR TREATMENT OF AN OCULAR CONDITION | Mar 24, 2021 | Abandoned |
Array
(
[id] => 16990170
[patent_doc_number] => 20210228590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/204246
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204246
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204246 | TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF | Mar 16, 2021 | Abandoned |
Array
(
[id] => 17748336
[patent_doc_number] => 20220226539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMPOSITE SCAFFOLD CONTAINING DFO AND RHBMP-2, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/199835
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199835 | COMPOSITE SCAFFOLD CONTAINING DFO AND RHBMP-2, PREPARATION METHOD AND USE THEREOF | Mar 11, 2021 | Abandoned |